Browse Reports

Inflection Point Acquisition Corp. VI is a Cayman Islands-incorporated special purpose acquisition company (SPAC) that completed its IPO in March 2026. The IPO raised gross proceeds of $253 million through the issuance of units consisting of Class A ordinary shares and redeemable warrants. The company also completed a private placement of warrants generating additional proceeds. The funds raised are held in a trust account, with limited amounts available for working capital. As a SPAC, the company has not disclosed any operating business, revenue, or industry focus to date.

BluSky AI Inc. is a Nevada-based company specializing in AI compute infrastructure through modular data centers designed for high-density GPU workloads. The company’s business model depends on securing powered lands with committed power infrastructure and integrating renewable energy sources. It faces operational challenges including supply chain volatility for GPUs and renewable energy components, competition from large hyperscale data center providers, and regulatory compliance costs. The company has incurred losses since inception and currently operates with limited liquidity, raising concerns about its ability to sustain operations without additional financing. BluSky AI also faces risks related to cybersecurity, legal proceedings, and reputational factors tied to its ESG commitments.

Cantor Equity Partners VI, Inc. is a special purpose acquisition company (SPAC) incorporated in April 2021 in the Cayman Islands. It completed its initial public offering on February 6, 2026, raising $115 million by issuing Class A ordinary shares. The company’s strategy is to identify and acquire a target business primarily in financial services, digital assets, healthcare, real estate services, technology, or software industries. The management team and Sponsor have extensive experience in sourcing, structuring, and growing businesses. The company holds IPO proceeds in a Trust Account invested in U.S. government securities or money market funds until a business combination is completed or the funds are returned to shareholders. The company must complete a business combination by February 6, 2028, with possible extensions. The post-combination company must own or control at least 50% of the target. The company’s shares trade on Nasdaq under the ticker CEPS.

Melar Acquisition Corp. I is a Cayman Islands exempted company engaged in a business combination with Everli Global Inc., an Italian e-grocery marketplace. The combination involves a $180 million transaction intended to take Everli public. Melar's securities trade on Nasdaq under multiple tickers including MACI. The company has entered into multiple amendments to secured promissory notes with Everli and its stockholders, reflecting financing arrangements to support the business combination and Everli's operations. As of March 31, 2026, Melar reported current assets of approximately $4.01 million and current liabilities of approximately $5.13 million, with a current ratio below 1, indicating liquidity constraints. The company reported net income of approximately $778,000 for the quarter ending March 31, 2026. The business combination is subject to customary closing conditions and regulatory approvals.

Alpha Modus Holdings, Inc. develops and licenses patented AI and data-driven technologies designed to enhance consumer engagement in physical retail environments. Founded in 2014 and headquartered in North Carolina, the company’s technology converts consumer interaction data into actionable insights for personalized marketing, inventory management, and customer assistance. Its business model emphasizes intellectual property licensing and enforcement, supported by a portfolio of eleven issued U.S. patents and pending applications. The company also operates Alpha Modus Financial Services, LLC, which offers the Alpha Cash platform providing financial services to underbanked consumers through mobile and kiosk solutions. Alpha Modus pursues commercialization through strategic partnerships with retailers, technology providers, and financial institutions, alongside active patent litigation to protect its IP rights.

Globa Terra Acquisition Corp is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in October 2024. Its business purpose is to effect a merger or similar business combination with one or more target companies, focusing on agribusiness and water sectors, including food-tech, ag-tech, bio-tech, controlled environment agriculture, water utilities, treatment, pipelines, and desalination. The company completed its IPO in July 2025, raising approximately $175 million, which is held in a trust account invested in U.S. government securities. The company has not generated operating revenues and is currently searching for a suitable business combination target. Its strategy emphasizes ESG principles, vertical integration, and leveraging management’s prior SPAC and public company experience to create long-term value post-combination. The geographic focus is the Americas, with particular emphasis on North America and production in Latin America to optimize costs and margins.

IRIDEX CORP develops and commercializes ophthalmic laser technologies for treating glaucoma and retinal diseases. Its proprietary MicroPulse® and Endpoint Management™ technologies enable tissue-sparing laser therapies. The company’s product portfolio includes laser consoles and single-use delivery probes across glaucoma, medical retina, and surgical retina segments. Sales are conducted directly in the US and Germany and through distributors internationally. Recurring revenue streams arise from consumable probes and service contracts. The company operates leased facilities in the US, Germany, and the Philippines. Fiscal 2025 revenues increased 8.2% to $52.7 million, with net losses narrowing compared to 2024. Gross margin compression was due to inventory write-downs and tariff impacts. Liquidity metrics as of April 2026 indicate a current ratio of 1.92 and cash ratio of 0.36. The company faces risks from macroeconomic uncertainty, supplier dependencies, currency fluctuations, and regulatory reimbursement changes [S1][S2].

Sono Group N.V. is a holding company with subsidiaries including Sono Motors GmbH and Sono Group S.à r.l. Historically, the company developed and planned to manufacture electric vehicles with integrated solar panels, notably the Sion passenger car program. However, in February 2023, the company terminated this program and pivoted its business model to focus exclusively on retrofitting and integrating solar technology. The company has since exited its legacy solar operations as of May 2026 and adopted a digital asset treasury strategy. Sono Group's shares began trading on Nasdaq in September 2025. The company has engaged in multiple financing arrangements with Yorkville, involving convertible debentures and preferred shares convertible into ordinary shares. Management is based in the United States, with operational headquarters in Munich, Germany. The company has reported limited revenue and recurring operating losses primarily due to its solar technology subsidiary. Recent activities include strengthening partnerships, commercial expansion in Europe, and leadership transition.

Oxley Bridge Acquisition Ltd is a Cayman Islands exempted blank check company incorporated in August 2024. It was formed to effect a Business Combination with one or more businesses, focusing on global consumer and technology sectors with disruptive growth potential through technology, primarily in Asia excluding China, Hong Kong, and Macau. The company completed its IPO in June 2025, raising $253 million, and placed the proceeds in a Trust Account. It has not yet selected a Business Combination target and has no operating revenues. The company aims to acquire businesses with enterprise values between $500 million and $1 billion that would benefit from being publicly traded in the U.S. Its management team combines enterprise builders and investment specialists with extensive experience. The company must complete its Business Combination by June 26, 2027, or liquidate and distribute Trust Account funds to shareholders. The company reported strong liquidity as of March 31, 2026, with cash and equivalents of $816,134 and a current ratio of 6.55.

Byrn, Inc. was established in 2011 as a healthcare knowledge solutions company developing medical software to improve clinical outcomes and reduce costs. The company was dormant from 2013 to 2019, after which it underwent custodianship and ownership restructuring. It changed its name multiple times and attempted a share exchange that was later voided, resulting in dormancy from 2021 through mid-2023. Prior to dormancy, Byrn specialized in digital, data-led solutions for retail supply chains and online transactions. As of the latest filings, the company has no active business operations and is considered a dormant shell.

Wellgistics Health, Inc. is a healthcare technology company focused on improving pharmaceutical supply chain transparency, patient access, and cost efficiency in the US market. The company provides pharmacy benefit management services, digital health solutions, and collaborates with partners to distribute and promote healthcare products and services. Wellgistics has formed strategic partnerships and joint ventures, including a notable collaboration with Kare PharmTech to commercialize benefits verification products. The company also engages in initiatives to enhance healthcare infrastructure, such as implementing blockchain-based payment solutions and marketing novel medical foods addressing specific health conditions. Leadership includes experienced executives with backgrounds in pharmacy, healthcare technology, and finance. The company is publicly traded on NASDAQ and files regular reports with the SEC.

Cisco Systems Inc operates in the communication equipment industry, providing networking hardware, software, and services. The company serves diverse customer segments including service providers, cloud customers, and enterprises. Cisco's business is subject to fluctuations in demand, supply chain challenges, and competitive pressures from global and regional players. The company manages inventory and supply chain risks through purchase commitments and supplier agreements. Cisco is focusing on growth areas such as AI, cloud computing, and cybersecurity, aligning its product portfolio and investments accordingly. The company maintains a stock repurchase program and has a significant presence in global markets, facing risks from geopolitical and economic uncertainties.

Red Robin Gourmet Burgers, Inc. is a Delaware corporation operating casual dining restaurants primarily in North America. The company is known for its gourmet burgers served with Bottomless Steak Fries and a variety of sides in a fun, family-friendly environment. Founded in 1969, Red Robin operates 475 restaurants as of the end of 2025, with 385 company-owned and 90 franchised locations. The menu includes over 20 burger varieties, including beef, chicken, turkey, vegetarian, and plant-based options, alongside other American favorites, desserts, and beverages. The company emphasizes customization, quality, and value, with an average guest check of $18.76 in fiscal 2025. Red Robin's strategic plan, 'First Choice,' launched in 2025, focuses on operational efficiency, marketing to drive traffic, expense management, restaurant improvements, and talent development. The company maintains rigorous food safety standards and engages in data-driven marketing. It also operates a partnership with Donatos® pizza in select locations. Financially, the company reported a net loss and liquidity challenges in Q1 2026, with ongoing efforts to refinance debt and improve financial performance.

Lakeside Holding Ltd, founded in 2018 and headquartered in Chicago, Illinois, is an Asian American-owned business specializing in integrated cross-border supply chain solutions with a strategic focus on the Asian market, including China and South Korea. The company provides customized cross-border ocean and air freight solutions tailored to customer needs for transporting goods into the U.S. Its services encompass freight consolidation and forwarding, customs clearance, warehousing and distribution, and U.S. domestic ground transportation. Lakeside operates three major regional warehousing and distribution centers in Illinois and Texas, with a combined area of approximately 142,484 square feet and 52 docks, supporting a daily freight volume of up to 3,000 cubic meters. The company collaborates with a broad network of over 150 warehouses and distribution terminals and more than 200 domestic ground transportation carriers. In late 2024, Lakeside expanded into pharmaceutical distribution through the acquisition of Hupan Pharmaceutical, based in Wuhan, China. The company leverages proprietary technology platforms to optimize logistics operations and maintains a workforce of 94 full-time employees as of mid-2025.

Oramed Pharmaceuticals Inc. develops orally ingestible drug delivery technologies, primarily focusing on oral insulin capsules and other biologics. The company has transitioned its POD platform and oral insulin program to Lifeward, a medical robotics and rehabilitation company, in exchange for a near 50% ownership stake, aligning Oramed with Lifeward's commercial portfolio and recurring revenue streams. Oramed continues to manage clinical trials for the oral insulin product through its subsidiary OraTech. Additionally, Oramed holds a significant equity position in Alpha Tau, which is advancing a novel alpha-radiation cancer therapy platform (Alpha DaRT) through multiple clinical trials and has received regulatory approval in Japan. Oramed's financial position includes cash, short-term investments, and marketable securities, with a history of net losses but recent net income driven by investment revaluations. The company faces operational risks related to personnel, joint ventures, regulatory approvals, and market conditions.

Akari Therapeutics Plc is a biotechnology company specializing in the development of next-generation antibody-drug conjugates (ADCs) for oncology. Its proprietary PH1 payload targets RNA splicing by modulating the spliceosome, leading to cancer cell death and immune system activation. The lead ADC candidate, AKTX-101, targets the Trop-2 receptor and has shown promising preclinical efficacy and potential synergy with checkpoint inhibitors. The company is advancing AKTX-101 toward clinical trials with a planned first-in-human Phase 1 study by late 2026 or early 2027. Additionally, Akari is developing AKTX-102, an ADC targeting CEACAM5, relevant in multiple solid tumors. The company relies on third-party manufacturers for GMP production and has filed patents protecting its technology. Akari has experienced operating losses and maintains a focus on research and development, supported by strategic partnerships and recent leadership appointments.

Envirotech Vehicles, Inc. develops and deploys electrified and energy-intensive hardware systems across multiple end markets. Its commercial EV segment offers Class 2-5 electric vehicles for fleet and institutional customers, manufactured by OEMs in Asia and assembled by the company. The medical supplies segment, via Maddox Industries, produces government-contracted medical products domestically. The drone segment is developing heavy-lift industrial drones for agriculture, fire suppression, and forestry, with manufacturing planned in the U.S. The company is also advancing modular AI data infrastructure integrating power generation and high-performance computing hardware. Operations have been centralized in Houston, Texas, with expanded manufacturing and technical workforce.

Educational Development Corporation is a publicly traded company listed on NASDAQ under the ticker EDUC. The company operates with a business model that includes ownership and leasing of its headquarters and distribution facilities, as evidenced by a recent sale and leaseback transaction. It maintains liquidity through cash reserves and a revolving credit facility secured by company assets. The company reported fiscal 2026 revenues of approximately $4.18 million and a net loss of $3.11 million, with negative earnings per share. The company holds scheduled earnings calls to communicate financial results and operational updates.

Capital Southwest Corp operates as an investment company focusing on debt and equity investments in portfolio companies. The company generates income primarily through interest, dividends, fees, and other investment-related income. It manages its capital structure through borrowings under credit facilities, issuance of unsecured notes, and equity offerings via an ATM program. The company also operates two Small Business Investment Company (SBIC) subsidiaries licensed by the SBA, which provide additional leverage through SBA Debentures. Capital Southwest maintains regulatory asset coverage ratios above required minimums and manages liquidity through cash, credit facilities, and capital markets access. Operating expenses mainly consist of interest on borrowings, employee compensation, and general administrative costs. The company actively manages its portfolio with realized gains and losses from investment exits and valuations.

Linkhome Holdings Inc. operates an artificial intelligence real estate platform called HomeGPT, designed to streamline and enhance the home buying and selling process. The platform integrates AI technology with financial innovation to provide end-to-end real estate solutions including brokerage services, a Cash Offer program that enables cash purchases to improve offer competitiveness, and mortgage services. The company also offers a Flash Sell service for quick home sales and a Buy Before Sell program to facilitate home transitions. Currently focused in California, Linkhome plans to expand geographically and broaden its service offerings to include title insurance, escrow, home insurance, property management, and home maintenance services. The platform supports over 1 million active residential listings and has facilitated over $180 million in transactions as of end 2025. The company completed its IPO in July 2025 and maintains strong liquidity as of Q1 2026.

Eagle Materials Inc. is a company operating in the materials sector, with publicly available financial data from its latest fiscal year ending March 31, 2026. The company demonstrates strong liquidity with a current ratio of 3.66 and a cash ratio of 1.15. Recent news coverage focuses on its Q4 2026 earnings results, which include a decline in earnings and profit but also reports of surpassing earnings and revenue estimates for the quarter. The company’s risk factors are referenced in its prior annual report filings but are not detailed here.

DeFi Development Corp. is a publicly traded company that manages a digital asset treasury strategy centered on the Solana blockchain ecosystem and operates a commercial real estate technology platform. The digital asset treasury segment focuses on acquiring, holding, and actively managing Solana (SOL) and SOL-related digital assets, including operating Solana validators and delegating SOL to external validators to earn staking rewards. The real estate platform connects commercial mortgage and small business borrowers with lenders such as banks, credit unions, REITs, and debt funds. The company uses institutional custodians and trading counterparties like Kraken, BitGo, and Galaxy Digital to manage its digital asset holdings. It has a sales agreement to raise capital through common stock offerings to support its treasury strategy and working capital needs.

SunPower Inc. is a technology-driven solar company focused on residential solar system sales and installation for homeowners, home builders, and small to medium-sized commercial customers. The company was formerly known as Complete Solaria, rebranded in 2025, and is headquartered in Orem, Utah. SunPower operates a national network of third-party sales partners and builder partners, providing a turnkey solar solution that includes software tools, sales support, and brand identity to enable competitive sales operations. The company manages the entire customer experience from contract initiation through installation and post-installation support. SunPower has expanded its operations through acquisitions including Sunder Energy, Ambia Energy, Cobalt Power Systems, and assets from SunPower Corporation, enhancing its sales force, installation capacity, and geographic reach. The company offers financing options and battery storage solutions through partnerships, aiming to provide energy-efficient solutions that reduce energy costs and carbon footprint. Its technology platform supports large-scale operations with integrated software for design, proposals, and project management. SunPower competes with traditional utilities and other solar providers by emphasizing customer experience, pricing, and operational efficiency. The company sources key components from select suppliers and maintains quality and cost controls. Financially, SunPower reported $72.8 million in revenue and $5.25 million in net income for Q1 2026, with liquidity ratios indicating current challenges in short-term asset coverage of liabilities. The company has issued convertible senior secured notes and faces risks related to supplier dependencies, regulatory changes, and financial covenants.

SunPower Inc. is a technology-driven solar company focused on delivering energy-efficient solar solutions to residential homeowners, new home builders, and small to medium-sized commercial customers across the United States. The company originated from the merger of Complete Solar Holding Corporation and The Solaria Corporation, rebranding as SunPower in 2025. It operates a national network of third-party sales partners and builder partners, managing the full lifecycle of solar system sales and installation. SunPower has expanded its footprint through strategic acquisitions, including Sunder Energy, Ambia Energy, Cobalt Power Systems, and assets from SunPower Corporation's bankruptcy proceedings. The company leverages proprietary and third-party software platforms to support sales, project management, and customer service. Its product offerings include solar modules, inverters, racking systems, battery storage, and car chargers. SunPower emphasizes a differentiated customer experience with tailored designs, pricing, and financing options. The company competes primarily with traditional utilities and other solar providers, focusing on price competitiveness, customer service, and broad product offerings. Financially, SunPower reported $72.8 million in revenue and $5.25 million in net income for Q1 2026, with liquidity ratios indicating a current ratio of 0.71 and a cash ratio of 0.06 as of March 29, 2026.

Northann Corp. focuses on additive manufacturing technology to produce innovative vinyl flooring and building solutions under the Benchwick and SuperOak brands. The company operates a vertically integrated model encompassing product design, manufacturing, and distribution, with a manufacturing facility in South Carolina currently operating at partial capacity. Northann serves primarily the U.S. and Canadian markets through wholesale distributors, major retail supermarkets, and local contractors. The company holds a portfolio of patents and is integrating AI technologies to enhance operations and customer experience. Financially, Northann reported $4.96 million in revenue and a net loss of $2.9 million for Q1 2026, with liquidity ratios indicating moderate short-term financial flexibility. The company has a concentrated customer base and faces risks related to raw material costs, competition, and economic cycles affecting construction and remodeling.

Nextpower Inc. (formerly Nextracker Inc.) is a leading global provider of solar and energy technology solutions focused on utility-scale solar power plants. Founded in 2013, the company pioneered solar tracking systems and remains the global market leader in this segment. Its flagship NX Horizon® solar tracker system features independent row tracking, self-powered motors, and a mechanically balanced design that enhances energy production, reliability, and ease of installation. The company’s integrated platform includes structural foundations, steel frames, electrical balance of systems (eBOS) solutions, and software platforms such as TrueCapture® and NX Navigator, which optimize energy yield and plant operability. Nextpower has expanded into AI and robotics services to improve solar plant deployment and operations. The company serves a diversified customer base across more than 40 countries, with a significant backlog and a global operational footprint. Its business model emphasizes innovation, integrated solutions, and long-term customer partnerships to support the growing demand for clean energy.

Mangoceuticals, Inc. operates in the pharmaceutical and wellness sectors, focusing on compounded pharmaceutical products, nutraceuticals, and telehealth-enabled wellness services. The company relies on a related-party pharmacy, Epiq Scripts, LLC, which provides compounding and pharmacy services across most U.S. states under a Master Services Agreement and Consulting Agreement. Mangoceuticals has expanded its product offerings through acquisitions of intellectual property and entry into new markets such as oral pouch delivery and women's telehealth wellness brands. The company has a limited operating history with recurring net losses and an accumulated deficit. Financial disclosures as of March 31, 2026, show modest revenue and significant net losses, with liquidity ratios indicating a current ratio of 0.29 and cash ratio of 0.24. The company is currently not in compliance with Nasdaq's minimum bid price requirements and has received a notification letter with a compliance deadline in August 2026. Regulatory risks are notable due to FDA scrutiny of compounding pharmacies and telehealth prescribing practices. Mangoceuticals depends on third-party logistics providers and faces risks related to counterfeit products, legal claims, and cybersecurity. The company continues to invest in product development, marketing, and intellectual property to support growth.

James Hardie Industries plc operates as a leading provider of exterior home and outdoor living solutions, with a product portfolio that includes fiber cement siding, trim, decking, railing, and accessories. The company expanded its footprint through the acquisition of AZEK in July 2025, integrating AZEK's environmentally sustainable outdoor living products and manufacturing facilities in the United States. Post-acquisition, James Hardie reports financial results across four segments: Siding & Trim, Deck, Rail & Accessories, Australia & New Zealand, and Europe. The company’s operations are closely tied to the residential and commercial construction markets, which are influenced by economic conditions, housing starts, and remodeling activity. James Hardie faces competitive pressures from various building material manufacturers and must manage risks related to raw material supply, manufacturing efficiency, product quality, and regulatory compliance. The company maintains significant indebtedness and is subject to legal proceedings related to its acquisition activities and product liability matters.

Driven Brands Holdings Inc. operates the largest automotive services platform in North America, with a network of over 4,200 locations spanning 49 U.S. states and Canada. The company’s services cover routine maintenance such as oil changes, as well as collision repair, paint, glass repair, and parts distribution. Its key segments include Take 5 Oil Change, Franchise Brands (including Meineke, Maaco, CARSTAR, and others), and Auto Glass Now. The company’s business model is a mix of franchised and company-operated locations, with a strong pipeline for new franchise openings and greenfield company-operated stores. Driven Brands leverages data analytics to optimize marketing, product offerings, and pricing, and provides shared services to its network to enhance margins and operational efficiency. The company reported approximately $1.86 billion in revenue for fiscal year 2025 and continues to focus on debt reduction and operational cash flow generation.

Corvex, Inc. is a Delaware-based public company trading on Nasdaq under the ticker MOVE. The company completed a merger in March 2026, acquiring Corvex Legacy Holdings, Inc. The leadership team and board comprise individuals with extensive experience in medical devices, technology, AI/ML platforms, and finance. The company reported modest revenue and a net loss for Q1 2026, with liquidity ratios indicating coverage of current liabilities. Equity compensation programs were implemented in 2025 due to liquidity challenges. The company is classified as a smaller reporting and emerging growth company. Specific details on the company's products, services, and industry classification are not explicitly disclosed in the available filings or news.

Doximity, Inc. operates as a physician-first technology platform designed to enhance productivity and patient care for medical professionals. The company has over 3 million registered members, including more than 85% of U.S. physicians, nurse practitioners, physician assistants, and medical students. Its platform provides AI-powered tools such as telehealth, clinical documentation, secure messaging, and an AI assistant for clinical questions. Doximity's business model includes Marketing Solutions for pharmaceutical and health system customers, Hiring Solutions for medical recruiting, and Workflow Solutions to streamline clinical operations. The company leverages network effects to expand its user base and improve its offerings continuously. It maintains a strong focus on HIPAA compliance, data security, and physician-centric design. Doximity also pursues strategic acquisitions to enhance its platform capabilities.

Silexion Therapeutics Corp is a clinical-stage biotechnology company incorporated in the Cayman Islands, specializing in RNA interference (RNAi) therapies for KRAS-driven cancers. Its lead product candidate, SIL204, has demonstrated positive preclinical efficacy in lung and pancreatic cancer models and is progressing towards Phase 2/3 clinical trials. The company has established strategic collaborations, notably with Catalent, to advance manufacturing and development. Silexion has conducted multiple financing rounds and warrant exercises to fund its operations and clinical development. The company maintains effective internal controls and has implemented share capital adjustments to support its growth and capital structure.

Cantor Equity Partners V, Inc. is a Cayman Islands-incorporated company that completed its initial public offering in November 2025, raising $250 million through the sale of Class A ordinary shares. The company simultaneously completed a private placement with its Sponsor. Proceeds from these offerings are held in a trust account pending the completion of an initial business combination. The company operates under the regulatory framework applicable to smaller reporting companies and has disclosed key financial metrics in its recent SEC filings.

Nauticus Robotics, Inc. develops and operates applied robotic solutions with a focus on deep-sea mineral exploration. The company expanded its capabilities through a $16 million asset acquisition in early 2025 and secured substantial equity financing to support growth initiatives. It manages a complex capital structure including convertible debentures and term loans, with recent amendments to loan agreements and equity facilities. The company is listed on Nasdaq and has taken steps to maintain compliance with listing requirements, including a reverse stock split and equity maintenance conditions. Leadership changes include the appointment of an interim CFO and a new Chief Revenue Officer in 2026.

Cantor Equity Partners IV, Inc. operates as a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in 2021. Its primary objective is to identify and complete a Business Combination with a target company, focusing on sectors including financial services, digital assets, healthcare, real estate services, technology, and software. The company completed its IPO in August 2025, raising $450 million, with proceeds held in a Trust Account invested in low-risk securities until the Business Combination is completed. The management team and Sponsor, affiliates of Cantor, bring experience in sourcing, structuring, and executing acquisitions, as well as operating and growing businesses. The company has a 24-month window from IPO to complete the Business Combination, extendable up to 36 months with shareholder approval. If unsuccessful, it will liquidate and redeem Public Shares at Trust Account value. The company currently has limited operations and no full-time employees prior to the Business Combination.

PAVmed Inc. operates as a diversified life sciences company with a focus on medical devices, diagnostics, and digital health through independently financed subsidiaries. Its primary subsidiaries are Lucid Diagnostics, which commercializes the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer and cancer in GERD patients, and Veris Health, which provides the Veris Cancer Care Platform for personalized cancer care and is developing an implantable physiological monitor. PAVmed also develops medical devices such as the PortIO implantable intraosseous vascular access device and licensed endoscopic imaging technology. The company pursues commercialization through multiple channels, including physician targeting, test centers, telemedicine, and strategic partnerships. It actively seeks insurance coverage and reimbursement, including Medicare reconsideration and contracts with the U.S. Department of Veterans Affairs. PAVmed reported a net loss and maintains liquidity with cash and current assets exceeding current liabilities as of March 31, 2026.